血友病治疗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00008241
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 225
Buy Now

2019年血友病治疗市场价值为127.9736亿美元,预计2027年将达到205.0792亿美元;预计 2020 年至 2027 年复合年增长率为 6.1%。

血友病是一种遗传性血液疾病,由于以下原因影响血液凝固能力缺乏凝血所需的特定蛋白质。血友病分为甲型血友病、乙型血友病和丙型血友病。许多重组药物,例如抗血友病因子或因子 VII,是可注射的。注射剂用于在手术前控制和预防出血事件,因为与其他形式相比起效较快。全球血友病治疗市场的增长归因于血友病患病率的增加和政府优惠举措的增加。然而,血友病治疗相关的高成本是阻碍市场增长的主要因素。

全球血友病治疗市场预计在疫情后将出现大幅增长。由于封锁、旅行禁令和企业关闭,COVID-19 已经影响了各国的经济和行业。 COVID-19 危机使许多国家的公共卫生系统负担过重,凸显了对卫生系统可持续投资的强烈需求。随着 COVID-19 大流行的进展,医疗保健行业的增长预计将下降。由于体外诊断产品需求的增加以及全球研发活动的增加,生命科学领域蓬勃发展。然而,由于进行的手术数量减少以及设备采购推迟或延长,医疗技术和成像领域的销售额正在下降。此外,医疗保健专业人员的虚拟咨询预计将成为大流行后的主流护理服务模式。随着远程医疗改变医疗服务方式,数字医疗将在未来几年继续蓬勃发展。此外,临床试验的中断以及随后药物上市的延迟预计也将为未来的完全虚拟试验铺平道路。 mRNA 等新技术预计将出现并改变制药行业,未来几年市场预计还将出现更多的垂直整合和合资企业。

全球血友病治疗市场利润丰厚的地区

市场洞察< /h3>

血友病患病率的增加将推动全球血友病治疗市场的增长

血友病是一种遗传性出血性疾病,会阻止血液正常凝固。主要症状是身体不同部位不受控制的自发性出血。根据国家血友病基金会 2020 年的数据,每 5,000 名活产男婴中就有 1 人患有 A 型血友病。 A 型血友病的发病率约为 B 型血友病的四倍。自 1994 年以来,美国血友病患者人数预计约为 20,000 人。此外,血友病的发病率在全世界尚不清楚;然而,这个数字很可能超过40万人。全球近75%的血友病患者要么未被诊断,要么接受不同的治疗。

在意大利,根据国家生物技术信息中心(NCBI)2017年的数据,登记的血友病患者人数此类疾病从 2000 年的约 7,000 例增加到 2011 年的约 8,500 例,2015 年则超过 11,000 例。这一趋势是由于记录的患者数量激增所致,主要是患有 1 型 vWD、轻度血友病或其他因素的患者

该病在亚洲国家的患病率也在以惊人的速度增加。例如,根据澳大利亚血友病基金会2020年的报告,该国有超过2800人被诊断出患有不同程度的血友病。

因此,血友病患病率的增加、血友病漏诊病例的增加以及医疗基础设施的改善将最终推动预测期内血友病治疗市场的增长。

基于产品的洞察

从产品角度来看,全球血友病治疗市场分为血浆源性凝血因子浓缩物、重组凝血因子浓缩物、去氨加压素和抗纤溶药物。 2019年,血浆源性凝血因子浓缩物细分市场占据最大份额。然而,预计重组凝血因子浓缩物细分市场在预测期内的复合年增长率最高。

全球血友病治疗市场(按产品) 2019年和2027年


基于疾病的见解

基于疾病的全球血友病治疗市场分为血友病 A、血友病 B 和血友病 C。血友病 A 细分市场在 2019 年占据最大的市场份额。然而,血友病 B 细分市场预计在预测期内将以最快的速度增长。

基于治疗类型的见解

根据治疗类型,全球血友病治疗市场分为预防治疗和按需治疗。预防领域在 2019 年占据了最大的市场份额。然而,按需领域预计在预测期内将以最快的速度增长。

基于治疗洞察

根据治疗,全球血友病治疗市场分为替代疗法、ITI疗法和基因疗法。替代疗法细分市场在 2019 年占据了最大的市场份额。此外,预计同一细分市场在预测期内的复合年增长率最高。

基于最终用户的见解

就最终用户而言,全球血友病治疗市场分为医院和医院。诊所、血友病治疗中心和门诊手术中心。医院和诊所细分市场在 2019 年占据最大市场份额,预计该细分市场在预测期内将以最快的速度增长。

战略见解

全球血友病治疗市场参与者正在采取产品推出和扩张策略,以满足全球不断变化的客户需求,这也使他们能够在全球范围内保持自己的品牌声誉。

 < /p>

全球血友病治疗市场 –按产品

  • 血浆衍生凝血因子浓缩物
    • 因子 VIII
    • 因子 IX
    • 因子 XII
    • 活化凝血酶原复合物浓缩物
    • 血管性血友病因子
  • 重组凝血因子浓缩物
    • 因子VIII
    • 因子IX
  • 抗纤维蛋白溶解剂
  • 去氨加压素

全球血友病治疗市场 -按疾病分类

  • 血友病 A
  • 血友病 B
  • 血友病 C

全球血友病治疗市场按治疗类型

  • 预防
  • 按需治疗

全球血友病治疗市场 -按治疗方法

  • 替代疗法
  • ITI疗法
  • 基因疗法

全球血友病治疗市场——由最终用户提供

  • 医院和医院诊所
  • 血友病治疗中心
  • 门诊手术中心

全球血友病治疗市场 -按地理位置

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • < li>欧洲
    • 法国
    • 德国
    • 意大利
    • 英国
    • 西班牙
    • 休息欧洲
  • 亚太地区 (APAC)
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳大利亚
    • 亚太地区其他地区
  • 中东和非洲非洲 (MEA)
    • 南非
    • 沙特阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲 (SCAM)
    • 巴西
    • 阿根廷
    • 其他 SCAM
  • < /ul>

    公司简介

    • 拜耳股份公司
    • 赛诺菲
    • F 。 Hoffmann-la Roche Ltd.
    • Kedrion SPA
    • CSL Limited
    • Biotest AG
    • 辉瑞公司
    • 诺和诺德公司
    • Octapharma AG
    • 百特国际公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are hemophilia treatment?

Hemophilia is a condition where blood does not clot, and this condition is normally inherited. The condition is caused due to defects in a gene of the X chromosome, which is a clotting factor. Generally, the diseases are widely seen in males as the X chromosome is inherited from mother to baby boy. The treatment of disease includes replacement therapy and gene therapy. The condition can be prevented by taking preventive treatment by injection of clotting factor VIII for hemophilia A, or IX for hemophilia B.

What are the driving factors for the hemophilia treatment market across the globe?

Rise in increasing prevalence of hemophilia, rise in favourable government initiatives to drive the growth of the global hemophilia treatment market during the forecast period. Moreover, growth of healthcare infrastructure among the untapped nations and increased initiatives taken up by governments are expected to fuel the growth of this market during the forecast period.

What is the therapy used in hemophilia treatment?

There are various type of therapy used in the treatment of hemophila disorder, such as replacement therapy, ITI therapy and gene therapy.

The List of Companies - Hemophilia Treatment Market

  1. Bayer AG
  2. Sanofi
  3. F. Hoffmann-la Roche Ltd.
  4. Kedrion S.P.A.
  5. CSL Limited
  6. Biotest AG
  7. Pfizer Inc.
  8. Novo Nordisk A/S
  9. Octapharma AG
  10. Baxter International Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports